Morgan Stanley’s Lux Health Tech Acquisition Corp. Units LUXAU Stock Holding History

Morgan Stanley’s Portfolio LUXAU Stock Details LUXAU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,756	Closed	-$37K	–	8207
2022 Q1	$37K	Hold	3,756	–	–	﹤0.01%	6853
2021 Q4	$38K	Sell	3,756 -300	-7%	-$3.05K	﹤0.01%	6942
2021 Q3	$41K	Sell	4,056 -23,311	-85%	-$238K	﹤0.01%	6806
2021 Q2	$281K	Sell	27,367 -12,753	-32%	-$133K	﹤0.01%	5847
2021 Q1	$429K	Buy	40,120 +20,541	+105%	+$243K	﹤0.01%	5239
2020 Q4	$225K	Buy	+19,579	New	+$210K	﹤0.01%	5533

Other funds holding LUXAU

BBR Partners New York $1.79B AUM 16.83% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

SMA

Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

SFM

Spartan Fund Management Toronto, Ontario, Canada $30M AUM 11.98% 1-Year Est. Return

Morgan Stanley's LUXAU Position: Q2 2022 in Review

Morgan Stanley sold out of Lux Health Tech Acquisition Corp. Units (LUXAU) in Q2 2022, closing a stake of 3,756 shares — an estimated $37K sold.

Morgan Stanley first reported a position in LUXAU in Q4 2020 and held it in 6 quarters. The position peaked at $429K in Q1 2021. 14 funds tracked by Wall St. Rank hold LUXAU as of Q2 2022.

Morgan Stanley reported no remaining Lux Health Tech Acquisition Corp. Units position as of Q2 2022 after selling out during the quarter.
Morgan Stanley sold 3,756 Lux Health Tech Acquisition Corp. Units shares in Q2 2022, an estimated $37K.
Morgan Stanley first reported a position in Lux Health Tech Acquisition Corp. Units in Q4 2020 and held it in 6 quarters.
Morgan Stanley's Lux Health Tech Acquisition Corp. Units position peaked at $429K in Q1 2021.
14 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Units as of Q2 2022.

Based on Morgan Stanley's 13F filing for Q2 2022, filed 15 Aug 2022.